| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Schechter Jonathan serves as a Director at PMCB and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 6 buys and 1 sell. Those positions are worth an estimated $222K at current prices.
Historically, Schechter Jonathan's trades have earned a strong insider score of 72/100 across 7 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +77.2%.
The biggest single holding is PMCB (~$106K). Net of sales, the recent Form 4 record there shows accumulation of 60,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | PMCB Pharmacyte Biotech, Inc. | - | Buy | 60,000 | $0.80 | $48,232.00 | +13.1% | -17.9% | - | |
| Nov 14, 2025 | TWAV Taoweave, Inc. | Director | Buy | 10,000 | $1.91 | $19,100.00 | +66.7% | -53.3% | - | |
| Sep 17, 2025 | TWAV Taoweave, Inc. | Director | Buy | 5,000 | $2.70 | $13,475.50 | +50.0% | -19.1% | - | |
| Sep 16, 2025 | TWAV Taoweave, Inc. | Director | Buy | 10,000 | $2.73 | $27,321.00 | New | -13.2% | - | |
| Dec 16, 2022 | TAOX Tao Synergies Inc. | Director | Sell | 20,250 | $1.17 | $23,730.98 | -41.5% | -29.9% | -77.2% |